Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Dowling

Showing results (11-20 of 68) with videos related to

Pageof 7
Sort By:
Trends in Immunology|April 23, 2025
mRNA vaccines: miRNA-based controlled biodistribution and directed adjuvantationByron Brook, Morgan Goetz, Valerie Duval, et al.
Frontiers in Immunology|February 28, 2022
Precision Vaccine Development: Cues From Natural ImmunitySoumik Barman, Dheeraj Soni, Byron Brook, et al.
Pediatric Research|September 14, 2020
The sixth revolution in pediatric vaccinology: immunoengineering and delivery systemsDheeraj Soni, Sharan Bobbala, Sophia Li, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 19, 2022
Precision Vaccine Adjuvants for Older Adults: A Scoping ReviewEtsuro Nanishi, Asimenia Angelidou, Chloe Rotman, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 22, 2024
An ionic liquid-based adjuvant for modulating cellular and humoral immune responsesMorgan J Goetz, Kyung Soo Park, Maithili Joshi, et al.
Pediatric Research|January 11, 2017
Pentoxifylline inhibits TLR- and inflammasome-mediated in vitro inflammatory cytokine production in human blood with greater efficacy and potency in newbornsEsther M Speer, David J Dowling, Lukasz S Ozog, et al.
STAR Protocols|July 15, 2023
A protocol for high-throughput screening for immunomodulatory compounds using human primary cellsKatherine Chew, Branden Lee, Al Ozonoff, et al.
Veterinary Parasitology|October 2, 2012
Identification of the major proteins of an immune modulating fraction from adult Fasciola hepatica released by Nonidet P40Russell M Morphew, Clare M Hamilton, Hazel A Wright, et al.
ACS Nano|June 27, 2025
Nanomedicine and Spleen-Targeting Strategies for Precision Immunomodulation: Advances, Challenges, and Future PerspectivesChiwoo Oh, Han Na Jung, Jiwoo Park, et al.
Infection and Immunity|April 1, 2009
The Fasciola hepatica tegumental antigen suppresses dendritic cell maturation and functionClare M Hamilton, David J Dowling, Christine E Loscher, et al.
Pageof 7

Showing results (11-20 of 68) with videos related to

Sort By:
Pageof 7
Trends in Immunology|April 23, 2025
mRNA vaccines: miRNA-based controlled biodistribution and directed adjuvantationByron Brook, Morgan Goetz, Valerie Duval, et al.
Frontiers in Immunology|February 28, 2022
Precision Vaccine Development: Cues From Natural ImmunitySoumik Barman, Dheeraj Soni, Byron Brook, et al.
Pediatric Research|September 14, 2020
The sixth revolution in pediatric vaccinology: immunoengineering and delivery systemsDheeraj Soni, Sharan Bobbala, Sophia Li, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 19, 2022
Precision Vaccine Adjuvants for Older Adults: A Scoping ReviewEtsuro Nanishi, Asimenia Angelidou, Chloe Rotman, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 22, 2024
An ionic liquid-based adjuvant for modulating cellular and humoral immune responsesMorgan J Goetz, Kyung Soo Park, Maithili Joshi, et al.
Pediatric Research|January 11, 2017
Pentoxifylline inhibits TLR- and inflammasome-mediated in vitro inflammatory cytokine production in human blood with greater efficacy and potency in newbornsEsther M Speer, David J Dowling, Lukasz S Ozog, et al.
STAR Protocols|July 15, 2023
A protocol for high-throughput screening for immunomodulatory compounds using human primary cellsKatherine Chew, Branden Lee, Al Ozonoff, et al.
Veterinary Parasitology|October 2, 2012
Identification of the major proteins of an immune modulating fraction from adult Fasciola hepatica released by Nonidet P40Russell M Morphew, Clare M Hamilton, Hazel A Wright, et al.
ACS Nano|June 27, 2025
Nanomedicine and Spleen-Targeting Strategies for Precision Immunomodulation: Advances, Challenges, and Future PerspectivesChiwoo Oh, Han Na Jung, Jiwoo Park, et al.
Infection and Immunity|April 1, 2009
The Fasciola hepatica tegumental antigen suppresses dendritic cell maturation and functionClare M Hamilton, David J Dowling, Christine E Loscher, et al.
Pageof 7